KINIKSA PHARMACEUTICALS INTE
KNSANASDAQ🏆 #973 by market capEarnings Feb 22US Equity
$95.26▲ $6.22 (+6.99%)
Market closed · at closeTrack KNSA
Get earnings, price moves & breaking news on Telegram
24h▲ 7.0%
7d▲ 17.9%
14d▲ 19.2%
30d▲ 25.7%
ytd▲ 131.3%
1y▲ 154.1%
🏦Market Cap
$7.43B
Small Cap
📈Revenue Growth (YoY)
60.1%
High Growth
📊Gross Margin
54.3%
Healthy
💵FCF Margin
20.9%
Strong
⚖️P/S Ratio
7.9x
Fair
Otter Score
68
Fair
Earnings
Q2 · 2026Reported 2026-06-30Earnings Per Share
Actual
0.30
Expected
0.30
miss
−1.50%
Revenue
Actual
—
Expected
—
—
—
Consensus estimates
Recent quarters
Q2 2026
0.30
miss
Q1 2026
0.27
beat
Q4 2025
0.17
miss
Q3 2025
0.23
miss